Pharmadrug Inc. (LMLLF)
OTCMKTS
· Delayed Price · Currency is USD
0.0064
-0.0009 (-12.33%)
Apr 22, 2025, 4:00 PM EDT
Pharmadrug Statistics
Total Valuation
Pharmadrug has a market cap or net worth of 776,722. The enterprise value is 1.82 million.
Market Cap | 776,722 |
Enterprise Value | 1.82M |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +89.92% |
Shares Change (QoQ) | +3.74% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 107.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -0.80 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.19 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
Current Ratio | 0.10 |
Quick Ratio | 0.07 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.76 |
Financial Efficiency
Return on equity (ROE) is -381.64% and return on invested capital (ROIC) is -15.82%.
Return on Equity (ROE) | -381.64% |
Return on Assets (ROA) | -12.38% |
Return on Invested Capital (ROIC) | -15.82% |
Return on Capital Employed (ROCE) | 96.26% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.17% in the last 52 weeks. The beta is 2.95, so Pharmadrug's price volatility has been higher than the market average.
Beta (5Y) | 2.95 |
52-Week Price Change | -73.17% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 33.97 |
Average Volume (20 Days) | 33,357 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -930,965 |
Pretax Income | -10.54M |
Net Income | -9.75M |
EBITDA | -890,303 |
EBIT | -930,965 |
Earnings Per Share (EPS) | -0.10 |
Balance Sheet
The company has 94,838 in cash and 1.04 million in debt, giving a net cash position of -942,812.
Cash & Cash Equivalents | 94,838 |
Total Debt | 1.04M |
Net Cash | -942,812 |
Net Cash Per Share | n/a |
Equity (Book Value) | -967,109 |
Book Value Per Share | -0.01 |
Working Capital | -1.39M |
Cash Flow
Operating Cash Flow | -776,298 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Pharmadrug does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -89.92% |
Shareholder Yield | -89.92% |
Earnings Yield | -1,254.98% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 24, 2023. It was a reverse split with a ratio of 0.1428571.
Last Split Date | Oct 24, 2023 |
Split Type | Reverse |
Split Ratio | 0.1428571 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |